Galimedix Therapeutics, Inc. |

Galimedix Therapeutics, Inc.

Galimedix is a Phase 2 clinical-stage private biotechnology company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious eye and brain diseases. Founded by a seasoned and highly dedicated team of bio-entrepreneurs, pharmaceutical executives, and scientists, Galimedix’s groundbreaking small molecules
administered orally or as eye drops offer the hope of changing the course of disease where amyloid beta (Aβ) plays a role, such as in Alzheimer’s disease (AD), dry age-related macular degeneration (dAMD)/ geographic atrophy (GA), and glaucoma (including normal tension glaucoma)- Galimedix’s areas of focus.

Field of Activity	Current areas of focus are Alzheimer’s disease, dry age-related macular degeneration/geographic atrophy (GA), and glaucoma, including normal tension glaucoma (NTG).
Ownership Structure and Financing	Private, seeking additional investors for a crossover round as preparation for an US-IPO.
Partners	Théa Open Innovation – development & commercialization of GAL-101 for dAMD, glaucoma & other ophthalmic indications in Europe, the Americas, the Middle East & Africa Seeking partners for GAL-101 – ophthalmology, Greater China, Asia/Pacific GAL-101 – AD, global GAL-201 – AD, global
Technology	Stopping neurodegeneration at its source – small molecules designed to address Aß early, preventing the formation of toxic Aβ oligomers that lead to disease.
Products/Services	GAL-101 (eye drops) – Phase 2 ready – dAMD, glaucoma GAL-101 (oral) – Phase 1 ready – AD, dAMD, glaucoma GAL-201 (oral) – IND-enabling ready – AD, other indications
Unique Selling Point	Prevents formation of all toxic Aβ species Aβ-detoxifying activity long-lasting post single application For all stages of the respective diseases Easy to produce, stable, low COGs Patient-friendly administration: oral, eye drops

Contact

Alexander Gebauer, M.D., Ph.D. Co-founder, Executive Chairman

Address	3704 Calvend Lane Kensington, MD 20895 USA
Telephone/	+1 301 917-9191
E-Mail	info@galimedix.com
Web Address	www.galimedix.com/
Date of Incorporation/Number of Employees	2018/10

ARTIKEL ZU DIESEN SCHLAGWORTEN